That's a good question and I am afraid no one can answer.
I don't recommend to buy because I never do so, but if I would own too less shares I would buy. Being invested in Mymetics for more than five years, buying every year and never selling made me own a really good stake in relation to my possibilities.
If there are no pitfalls I think as well this company should be in Dollars. The only obvious reason is not being listed on a "better" exchange. I think it would change a lot if MYMX would be tradeable at Nasdaq.
Perhaps there's something in the filings I don't know making current market capitalization a fair value.
Today is deadline for the Anergis deal. I can't wait to know what becomes of it.
I am surprised we had to wait till the last day. If financing is secured why to wait for the last hours? I don't think Anergis intentionally waits so long.
Therefore I am wondering if the LCA is not anymore under discussion. If so, our management needs to wait until Monday, thus expiration of Anergis' deadline and then tell us what's going on. I will continue dreaming about a big structure changing deal.
News 
Market Data 
Discover 
AI
